
Cardiology
Research on thymosin beta-4, an actin-binding peptide studied in tissue repair, cardiac injury models, and regenerative biology.
No claims extracted for this topic
Direct activation of tachykinin receptors within baroreflex afferent pathway and neurocontrol of blood pressure regulation
CNS Neuroscience & Therapeutics — Yuan M — Jun 2018
MRGPRX2 Activation Worsens Adverse Cardiac Remodeling and Causes Mast Cell Degranulation
Physiology — Schafner K — May 2026
Regulation of Aldosterone Secretion by Substance P and the Neurokinin Type 1 Receptor in Aldosterone‐Producing Adenomas
Journal of the American Heart Association — Lopez A — Jan 2026
Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.
Thymosin beta-4 (also known as Thymosin beta-4, TB-500, Tβ4). Research on thymosin beta-4, an actin-binding peptide studied in tissue repair, cardiac injury models, and regenerative biology.
As of 2026-08-14, the scientific consensus on Thymosin beta-4 is unknown. No claims extracted for this topic
This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/peptide-thymosin-beta-4.
Deterministic synthesis from Synapse's enriched corpus — 54 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.
Explore every Thymosin beta-4 paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.
Search Thymosin beta-4 papersPowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers